Get the Stockscreener App
640.66
1.92%
-12.53
Pre-market:
640.73
0.07
+0.01%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Mckesson Corporation stock is traded at $640.66, with a volume of 641.59K.
It is down -1.92% in the last 24 hours and up +7.67% over the past month.
McKesson Corp is one of three leading pharmaceutical wholesalers in the us engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the us pharmaceutical wholesale industry. Outside the us market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
See More
Previous Close:
$653.19
Open:
$651.24
24h Volume:
641.59K
Relative Volume:
0.85
Market Cap:
$80.29B
Revenue:
$344.58B
Net Income/Loss:
$2.83B
P/E Ratio:
29.33
EPS:
21.84
Net Cash Flow:
$1.63B
1W Performance:
+0.16%
1M Performance:
+7.67%
6M Performance:
+25.33%
1Y Performance:
+20.60%
1-Day Range:
$635.00
$651.98
1-Week Range:
$626.33
$663.62
52-Week Range:
$464.42
$663.62
Mckesson Corporation Stock (MCK) Company Profile
Name
Mckesson Corporation
Sector
Industry
Phone
972-446-4800
Address
6555 STATE HIGHWAY 161, IRVING, TX
Compare MCK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MCK
Mckesson Corporation
|
640.66 | 80.29B | 344.58B | 2.83B | 1.63B | 21.84 |
|
COR
Cencora Inc
|
254.00 | 49.20B | 303.19B | 1.40B | -638.10M | 7.03 |
|
CAH
Cardinal Health Inc
|
126.83 | 30.89B | 222.16B | 1.31B | -486.00M | 5.36 |
|
HSIC
Henry Schein Inc
|
69.94 | 9.32B | 12.50B | 314.00M | 421.00M | 2.44 |
|
PDCO
Patterson Companies Inc
|
31.14 | 2.73B | 6.55B | 155.22M | -823.13M | 1.71 |
Mckesson Corporation Stock (MCK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-04-24 | Resumed | Mizuho | Neutral |
| Nov-07-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-24-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-05-24 | Reiterated | Leerink Partners | Outperform |
| Aug-08-24 | Reiterated | Mizuho | Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-14-23 | Initiated | Wells Fargo | Equal Weight |
| Mar-31-23 | Initiated | Citigroup | Buy |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| Jul-06-22 | Downgrade | Argus | Buy → Hold |
| Jun-07-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Feb-04-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Nov-02-21 | Reiterated | Barclays | Overweight |
| Nov-02-21 | Reiterated | BofA Securities | Buy |
| Nov-02-21 | Reiterated | Evercore ISI | Outperform |
| Nov-02-21 | Reiterated | Jefferies | Buy |
| Mar-30-21 | Upgrade | Argus | Hold → Buy |
| Nov-02-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-04-20 | Upgrade | Deutsche Bank | Hold → Buy |
| May-22-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| May-15-20 | Upgrade | UBS | Neutral → Buy |
| Apr-23-20 | Resumed | Credit Suisse | Neutral |
| Mar-18-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-13-20 | Upgrade | Guggenheim | Neutral → Buy |
| Feb-07-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-10-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-05-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-22-19 | Initiated | Guggenheim | Neutral |
| Jan-17-19 | Initiated | UBS | Neutral |
| Oct-26-18 | Reiterated | Barclays | Equal Weight |
| Jul-20-18 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-29-18 | Reiterated | Leerink Partners | Mkt Perform |
| Mar-08-18 | Initiated | Barclays | Equal Weight |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Feb-02-18 | Reiterated | Mizuho | Neutral |
| Jan-24-18 | Upgrade | Jefferies | Hold → Buy |
View All
Mckesson Corporation Stock (MCK) Latest News
McKesson (MCK) Stock Slides as Market Rises: Facts to Know Before You Trade - Nasdaq
GS1 US Presents Upcoming Free Webinar: How McKesson and Target Are Electrifying Their Supply Chains Using EPCIS to Share Product Data - Yahoo Finance
Is Trending Stock McKesson Corporation (MCK) a Buy Now? - Yahoo Finance
McKesson Co. (NYSE:MCK) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
Stocks Showing Market Leadership: McKesson Earns 91 RS Rating - Investor's Business Daily
Ambulatory Infusion Center Market Projected To Witness Substantial Growth 2025-2032:McKesson - EIN News
McKesson stock soars to all-time high of $653.97 amid robust growth By Investing.com - Investing.com South Africa
McKesson stock soars to all-time high of $653.97 amid robust growth - Investing.com India
Is McKesson Stock Outperforming the Dow? - Nasdaq
Is McKesson Stock Outperforming The Dow? - Barchart
McKesson Corporation (MCK) Surged on Increased Guidance - MSN
McKesson CEO Tyler Brian S. sells $5.68 million in stock - Investing.com India
Leerink Partners Adjusts Price Target on McKesson to $732 From $690, Keeps Outperform Rating - Marketscreener.com
Lumata Health Secures $23 Million Series B Funding Round Co-Led By Lrvhealth, Mckesson Ventures, Cencora Ventures - Marketscreener.com
McKesson Keeps Growing, Eyeing Bigger Future - Yahoo Finance
McKesson to Acquire Controlling Interest in PRISM Vision Holdings - The Healthcare Technology Report.
Global Healthcare Mobility Solutions Market to Exhibit Tremendous Growth at a CAGR of ~21% by 2032 | DelveInsight - GlobeNewswire Inc.
McKesson CEO Tyler sells $5.6 million in common stock By Investing.com - Investing.com South Africa
McKesson CEO Tyler sells $5.6 million in common stock - Investing.com India
McKesson stock hits record high - The Business Journals
Healthcare Distribution Market Projected To Witness Substantial Growth, 2025-2032: McKesson Corporation, - EIN News
McKesson (MCK) Reports Q4 Earnings: What Key Metrics Have to Say - MSN
McKesson stock soars to all-time high of $637.59 By Investing.com - Investing.com South Africa
McKesson stock soars to all-time high of $637.59 - Investing.com India
McKesson Stumbles On Missed Revenue Target Despite High Demand - Finimize
Home Infusion Therapy Market Projected To Witness Substantial Growth, 2025-2032: McKesson Corporation, - EIN News
Ex-Dividend Reminder: Clearway Energy, Universal Health Services and McKesson - Nasdaq
McKesson (NYSE:MCK) delivers shareholders enviable 33% CAGR over 5 years, surging 3.5% in the last week alone - Yahoo Finance
McKesson’s EVP Michele Lau sells shares worth $188,760 By Investing.com - Investing.com Australia
McKesson's EVP Michele Lau sells shares worth $188,760 - Investing.com
MCKESSON EVP and Chief Legal Officer Sells Shares - TradingView
Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now? - MSN
IBD Rating Upgrades: McKesson Flashes Improved Relative Price Strength - Investor's Business Daily
McKesson CEO Tyler Brian S. sells shares worth $5.36 million By Investing.com - Investing.com Australia
McKesson Stock: Analyst Estimates & Ratings - Nasdaq
McKesson CEO Tyler Brian S. sells shares worth $5.36 million - Investing.com
Healthcare Informatics Market Deep Research Report with Forecast by 2025-2032 | Cerner Corporation, McKesson - EIN News
With 89% ownership of the shares, McKesson Corporation (NYSE:MCK) is heavily dominated by institutional owners - Yahoo Finance
McKesson Faces Faith Accommodation Trial Over Covid Vaccine Rule - Bloomberg Law
Home Healthcare Software Market Projected To Witness Substantial Growth, 2025-2032:Agfa Healthcare, Mckesson - EIN News
McKesson (MCK) Stock Dips Amidst Market Fluctuations - GuruFocus.com
Impact ESG Analyst InternSummer 2025 - Built In
Baird Adjusts McKesson Price Target to $730 From $729, Maintains Outperform Rating - Marketscreener.com
Here's How Much You Would Have Made Owning McKesson Stock In The Last 5 Years - Benzinga
Peering Into McKesson's Recent Short Interest - Benzinga
Martin & Co. Inc. TN Has $6.73 Million Stock Holdings in McKesson Co. (NYSE:MCK) - MarketBeat
CIBC Asset Management Inc Reduces Holdings in McKesson Co. (NYSE:MCK) - MarketBeat
McKesson Co. (NYSE:MCK) Shares Sold by State of New Jersey Common Pension Fund D - MarketBeat
Legacy Capital Wealth Partners LLC Has $409,000 Stake in McKesson Co. (NYSE:MCK) - MarketBeat
Roxbury Financial LLC Buys Shares of 2,601 McKesson Co. (NYSE:MCK) - MarketBeat
Ingalls & Snyder LLC Purchases 1,047 Shares of McKesson Co. (NYSE:MCK) - MarketBeat
Mckesson Corporation Stock (MCK) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.56%
2.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):